New jab to help patients at risk of going blind from common condition

Tocilizumab, a drug that targets a chemical responsible for inflammation, could help countless people with giant cell arteritis (GCA).

Source: the Mail online | Health - July 9, 2018 Category: Consumer Health News Source Type: news